shows immunofluorescence with a Ki-67 and insulin staining. 
Intraperitoneal glucose tolerance test (IPGTT)

16
IPGTTs were performed at the end of the treatment protocols (day 12 or 28). Blood samples 17 were collected at 0, 30 and 60 min during IPGTT and were used to measured insulin levels 18 using a commercial ELISA kit (Mercodia), following the manufacturer's instructions. Results
19
were acquired using a spectrophotometer (VictorTM X4, 2030 Multilabel Reader, Perkin 20 Elmer) at 450 nm.
21
Immunofluorescence
22
Pancreas tissues were fixed overnight in 4% paraformaldehyde (PFA) and embedded in 23 paraffin. Then, the samples were sectioned into 5 μm thick slices, blocked in 10% bovine 24 serum albumin (Sigma-Aldrich), 3% no fat milk and 0.3% Triton X-100 PBS. For the 25 detection of Ki67, tissues were incubated overnight at 4°C with antibody (listed in Table S2) 26 diluted in PBS/0.3% Triton X-100/10% BSA/3% milk. Then tissues were incubated the next 27 day for 2 h at RT in the dark with respective secondary antibody (listed in Table S2 
